Clinical trials
Participation clinical trials
Below are recruiting participation clinical trials, each written for real people, not researchers. We’re tracking 2,283 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06831539RecruitingPhase 1
How bowel prep affects gut bacteria recovery
This study looks at how the bowel preparation medicine (PEG) used before a colonoscopy affects the bacteria living in your gut and how well they recover afterward. Healthy volunteers will take the bowel prep and provide stool samples to help researchers understand this process.
Montreal, QuebecAges 18–70 - NCT07380295Recruiting
Helping people with MS stay at work and feel better
This study tests a program to help people with multiple sclerosis (MS) stay active at work and improve their well-being. It is for adults aged 18 to 65 who have been referred for a neuropsychological assessment at Gävle Hospital.
GävleAges 18–65 - NCT07384650Recruiting
Nurse-led rehab to improve daily activity after stroke
This trial tests a nurse-led home rehabilitation program for stroke survivors in Bangladesh. It aims to help you move better, do daily tasks, and get more involved in your community.
Dhaka, Dhaka DivisionAges 18 years+ - NCT07373457RecruitingPhase 1
Testing a new drug in healthy volunteers
This early-stage study tests a new investigational drug called HW201877 in healthy volunteers. The goal is to see if the drug is safe and how the body processes it.
ChangchunAges 18–55 - NCT07372703RecruitingPhase 1
Safety study of VV913 capsules in healthy Chinese men
This study tests a new capsule called VV913 in healthy male volunteers to see how safe it is and how the body processes it. It is a first-in-human trial in China to gather basic safety information.
Hefei, AnhuiAges 18–45 - NCT07371455RecruitingPhase 1
LWP779 safety trial for healthy volunteers
This trial tests a new oral medication called LWP779 in healthy adults to see if it is safe and how the body processes it. It helps determine the right dose for future studies.
AdelaideAges 18–65 - NCT07377942Enrolling by invitation
Probiotic study for gut and immune health in healthy adults
This study tests a probiotic (a type of good bacteria) called Bacillus subtilis to see how it affects digestion and the immune system in healthy adults. It involves taking the product, giving stool samples, and visiting the clinic for checkups.
Bangalore, KarnatakaAges 18–50 - NCT07378527RecruitingPhase 2/Phase 3
Study of ICP-332 for chronic hives not helped by antihistamines
This trial tests an experimental drug called ICP-332 for people with chronic spontaneous urticaria (long-term hives) that is not well controlled by standard antihistamines. The goal is to see if the drug is safe and effective at reducing hives.
Bengbu, AnhuiAges 18–75 - NCT07375758RecruitingPhase 1/Phase 2
Testing MIL116 in healthy people and those with IgA Nephropathy
This study tests a new drug called MIL116 for IgA Nephropathy. First, healthy volunteers will test the drug's safety, then people with IgA Nephropathy will see if it can help reduce protein in their urine.
BeijingAges 18 years+ - NCT07371598Recruiting
Study of Royal Ancient Oats for healthy adults with higher weight
This trial tests if a special oat supplement (Royal Ancient Oats) can help adults who are overweight but not diabetic. You will need to follow a diet and avoid certain supplements and medications.
Kannapolis, North CarolinaAges 35–65 - NCT07371468RecruitingPhase 1
Study of an experimental drug for lupus, rheumatoid arthritis, and related conditions
This trial tests a new drug called GSK5926371 for people with certain autoimmune diseases that affect the joints, skin, and other tissues. It aims to see if the drug is safe and how well it works.
Buenos AiresAges 18–70 - NCT05127980Recruiting
Study of immune antibodies after first-time EBV infection
This study looks at how the immune system’s antibodies behave after a first-time EBV infection, including whether they mistakenly react with the body’s own tissues. You might be offered a chance to help doctors understand why some people get longer or more intense symptoms from infectious mononucleosis.
BaselAges 18 years+ - NCT07370168Enrolling by invitation
Do daily contact lenses need frequent checkups after initial fitting?
This study tests whether adults under 40 who wear daily disposable soft contact lenses need to come back for frequent eye exams after their first fitting. It aims to see if fewer checkups are safe and effective.
BirminghamAges 18–40 - NCT07367672Recruiting
How beliefs affect pain empathy
This trial studies how our expectations can change how we feel pain for others. It may help us understand the placebo effect better.
Chengdu, SichuanAges 18–30 - NCT07362407Enrolling by invitation
Cannabinoid treatment study for patients in Brazil
This study tracks how cannabis-based medicines work in real life. It looks at how people feel and function while using these treatments prescribed by their doctor.
Florianópolis, Santa CatarinaAges 18 years+ - NCT07364773Recruiting
Motivational interviewing to boost rehab in spinal cord injury
This study looks at whether motivational interviewing—a supportive conversation style—can help patients with spinal cord injury (SCI) participate more fully in their rehab therapy. If you are an adult with SCI receiving inpatient rehab at certain hospitals, you may be able to join.
Chicago, IllinoisAges 18 years+ - NCT07369011RecruitingPhase 3
Study of eloralintide for sleep apnea with obesity
This study tests an investigational medication called eloralintide to see if it can improve sleep apnea in people who are overweight or have obesity. You will receive either the study drug or a placebo (inactive shot), and your sleep and weight will be monitored over time.
Cullman, AlabamaAges 18 years+ - NCT07365319RecruitingPhase 2/Phase 3
New drug combo for stage 4 lung cancer
This trial tests a new drug called EIK1001 combined with standard immunotherapy (pembrolizumab) and chemotherapy for people with stage 4 non-small cell lung cancer who have not been treated before. The goal is to see if adding EIK1001 helps shrink tumors more than the current standard treatment.
Daphne, AlabamaAges 18 years+ - NCT07365241RecruitingPhase 3
Study of ABBV-706 vs standard care for advanced small cell lung cancer
This trial tests a new drug called ABBV-706 against standard treatments (topotecan, lurbinectedin, or amrubicin) for people with small cell lung cancer that has come back or stopped responding to previous therapies. The goal is to see if ABBV-706 works better at controlling the cancer.
Birmingham, AlabamaAges 18 years+ - NCT07363057RecruitingPhase 2
Study of GI-102 and GIB-7 for aging in healthy adults and cancer survivors
This trial tests whether a combination of two drugs, GI-102 and GIB-7, can affect markers of aging in healthy people and in people who have had cancer. It aims to see if these drugs might help slow or improve aging-related changes.
Charlestown, New South WalesAges 18–80 - NCT07368998RecruitingPhase 2
Study of inavolisib plus fulvestrant for advanced breast cancer
This trial tests whether a new targeted pill (inavolisib) plus hormone therapy (fulvestrant) can slow or stop breast cancer growth in people whose cancer has a specific genetic change called a PIK3CA mutation. It is for patients whose disease worsened after previous hormone-and-CDK-inhibitor treatment.
Los Angeles, CaliforniaAges 18 years+ - NCT07368972RecruitingPhase 2
Study of DISC-0974-201 for IBD and Anemia
This trial tests a new medicine called DISC-0974-201 for people with inflammatory bowel disease and anemia. It aims to see if the drug can improve anemia symptoms and is for people with mild disease activity who have not responded well to standard treatments.
Birmingham, AlabamaAges 18 years+ - NCT07370207RecruitingPhase 2
Study of AHB-137 for HBeAg negative chronic hepatitis B
This study tests a new medicine called AHB-137 for people with chronic hepatitis B who are HBeAg negative and currently on antiviral therapy. The goal is to see if it can help control the virus better or allow you to stop your current medication safely.
Fitzroy, VictoriaAges 18–65 - NCT07369076RecruitingPhase 1/Phase 2
Testing NB-4746 for people with ALS
This study tests an investigational drug called NB-4746 for people with ALS. The goal is to see if it can slow the progression of the disease. It is for people diagnosed within the last couple of years who are still able to eat and breathe on their own.
Concord, New South WalesAges 18–80
Hear when a new Participation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for participation?
- Yes. Clin2 currently lists 2,283 recruiting participation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a participation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a participation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.